LataMed AI Corp. (OTC: LMED), a digital health and artificial intelligence technology company focused on emerging markets, announced it has initiated an evaluation process to integrate installment-based healthcare payment capabilities through Cashea, a leading buy-now-pay-later platform in Venezuela. The initiative aims to reduce upfront financial barriers for patients seeking private healthcare services within the LataMed AI ecosystem.
By enabling patients to pay for consultations, diagnostics, wellness programs, and other eligible healthcare offerings over time, the company hopes to increase patient engagement, healthcare utilization, and platform adoption. Management believes that addressing affordability is key to expanding access to private healthcare in Latin America, where out-of-pocket costs often deter timely medical care.
Dr. Kevin Rodan Levy, CEO of LataMed AI, stated: “We believe financial accessibility is a critical component of healthcare delivery. Our objective is to evaluate solutions that may help patients obtain timely medical care while simultaneously expanding the reach and utility of our healthcare ecosystem.” He added that such initiatives could strengthen patient acquisition and support long-term platform growth.
The proposed integration is part of LataMed AI’s broader strategy to combine artificial intelligence, telehealth infrastructure, care coordination tools, and digital payment accessibility into a scalable healthcare marketplace. The company has not yet entered into a definitive commercial agreement, and completion of any integration remains subject to further discussions, technical implementation, regulatory review, and customary business conditions.
LataMed AI, which is traded on the OTC market, develops technology platforms designed to support healthcare access, patient engagement, provider coordination, and data-driven operations, with an initial focus on Latin America. The company’s SEC filings are available at www.sec.gov.
The news underscores a growing trend of fintech-healthcare convergence in emerging markets, where innovative payment solutions are being used to bridge gaps in healthcare affordability. For LataMed AI, a successful partnership with Cashea could differentiate its platform in a competitive landscape and drive adoption among price-sensitive patients. However, the company faces risks common to development-stage firms, including financing, regulatory hurdles, and operational execution in Venezuela’s challenging economic environment.
Investors should note that forward-looking statements in the release are subject to risks outlined in the company’s SEC filings, and no assurance can be given that the integration will materialize. LataMed AI intends to provide updates as developments occur.
This news story relied on content distributed by NewMediaWire. Blockchain Registration, Verification & Enhancement provided by NewsRamp
. The source URL for this press release is LataMed AI Evaluates Integration of Installment Payments via Cashea to Improve Healthcare Access in Venezuela.
The post LataMed AI Evaluates Integration of Installment Payments via Cashea to Improve Healthcare Access in Venezuela appeared first on citybuzz.


